The latest price target for Definitive Healthcare (NASDAQ:DH) was reported by BTIG on September 17, 2024. The analyst firm set a price target for $7.00 expecting DH to rise to within 12 months (a possible 59.09% upside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for Definitive Healthcare (NASDAQ:DH) was provided by BTIG, and Definitive Healthcare initiated their buy rating.

The last upgrade for Definitive Healthcare Corp happened on February 24, 2022 when Canaccord Genuity raised their price target to $28. Canaccord Genuity previously had a hold for Definitive Healthcare Corp.

The last downgrade for Definitive Healthcare Corp happened on July 31, 2024 when JP Morgan changed their price target from $7 to $5 for Definitive Healthcare Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Definitive Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Definitive Healthcare was filed on September 17, 2024 so you should expect the next rating to be made available sometime around September 17, 2025.

While ratings are subjective and will change, the latest Definitive Healthcare (DH) rating was a initiated with a price target of $0.00 to $7.00. The current price Definitive Healthcare (DH) is trading at is $4.40, which is within the analyst’s predicted range.